index	text	answer	document_name
0	"Changepoint, Inc. (""Changepoint"") shall be a direct and intended third-party beneficiary to this Agreement."	Yes	CHANGEPOINTCORP_03_08_2000-EX-10.6-LICENSE AND HOSTING AGREEMENT.PDF
1	Lessor and Lessee expressly agree that bw-3 is a third party beneficiary of this Addendum.	Yes	BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF
2	It is expressly agreed by the Parties that the Lenders shall be third party beneficiaries of Section 4.09, Section 6.03, Section 8.02(b), Section 8.04, Section 8.05 and this Section 8.13	Yes	SUCAMPOPHARMACEUTICALS,INC_11_04_2015-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF
3	Beginning in the second Contract Year, Wade will be available for a maximum of one (1) production day for creating marketing assets for Wade Products and Naked Products for unlimited use in advertisements and the media, for a maximum of three (3) consecutive hours, not including scheduled breaks, during such production day period.	No	NakedBrandGroupInc_20150731_POS AM (on S-1)_EX-10.75_9196027_EX-10.75_Endorsement Agreement.pdf
4	At the end of the sell-off period set forth in Section 12.3(c)(iii), Sanofi shall transfer to RevMed any and all inventory of SHP2 Inhibitors and Termination Products (including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like) then in the possession of Sanofi, its Affiliates or Sublicensees, and continue or have continued any ongoing stability studies pertaining to any materials so transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities	No	RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf
5	"In the event Bellicum's aggregate purchases of Miltenyi Products from Miltenyi under this Agreement in any Calendar Year during the Term is less than [...***...]% of the Rolling Monthly Forecast subject to Sections 5.1 and 5.3, at the beginning of that Calendar Year or â‚¬[...***...] ([...***...] Euros), whatever is higher, (the ""Minimum Purchase""), then Miltenyi shall provide written notice to Bellicum of such shortfall."	No	BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF
